{"url_path":"/sec/adgm/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 ****Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/2006986/0001104659-26-059027-index.html","accession_number":"0001104659-26-059027","cik":"0002006986","ticker":"ADGM","issuer_name":"Adagio Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2006986/0001104659-26-059027-index.html","primary_entity_key":"0002006986","primary_entity_name":"Adagio Medical Holdings, Inc."},"word_count":47,"has_tables":true,"body_markdown":"**Item 5.****Other Information.**\n\nDuring the three months ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.\n\n​\n\n52\n\n[Table of Contents](#TOC)"}